首页> 外文学位 >Cultural and leadership influences on pharmaceutical R and D team innovation.
【24h】

Cultural and leadership influences on pharmaceutical R and D team innovation.

机译:文化和领导力对制药研发团队创新的影响。

获取原文
获取原文并翻译 | 示例

摘要

The pain, suffering and financial toll that disease takes on the world is ever increasing, and those faced with a diagnosis or in the business of reversing it are in need of innovation more than ever. As major players in the healthcare industry, biopharmaceutical companies face internal and external challenges to innovate that are increasingly more difficult. These companies organize the work of drug development into primarily a team-based exercise. Research indicates that team leadership and culture can have an influence on team innovativeness. However, this is less well known in the biopharmaceutical industry. Additionally, the role of the team leader to leverage the team culture and or the larger, macro-culture of the overall organization is also less well known. This dissertation examines the following: How do team leaders in one specific company, "Biopharm," foster innovation? How do team members foster innovation? How does team and/or organizational culture foster or inhibit innovation? The results of this research indicate that team leaders primarily view innovation as something that involves re-imagining current processes, tool, and methods in order to better the standard of care. Team members, on the other hand, view innovation as being driven primarily by the managerial aspects of drug development (i.e. managing and improving timelines, cost, or quality). Although not thought of as traditional innovation, where a completely new product is introduced, these types of incremental innovations are important as they can mean saving time reaching the market, which can present a potentially multi-million dollar-a-day savings. At the macro level, these differing perceptions of innovation between team members and leaders create a tension on teams that leads to frustration. Additionally, the overall organizational culture demonstrates variable risk tolerance throughout and variable remit for autonomous thinking across teams. This research increases our understanding of innovation and teamwork in the biopharmaceutical industry and offers insight to senior management, team leaders, and team members as they strive to align their work practices in the spirit of finding the next big medical breakthrough.
机译:疾病给世界带来的痛苦,痛苦和经济损失正在不断增加,那些面临诊断或正面临着逆转疾病的人比以往任何时候都更需要创新。作为医疗保健行业的主要参与者,生物制药公司面临着内部和外部创新的挑战,这些挑战越来越困难。这些公司将药物开发工作主要组织为基于团队的活动。研究表明,团队领导和文化可以影响团队的创新能力。但是,这在生物制药工业中鲜为人知。此外,团队领导者发挥团队文化和/或整个组织更大的宏观文化的作用也鲜为人知。本文研究以下内容:一家“ Biopharm”特定公司的团队领导如何促进创新?团队成员如何促进创新?团队和/或组织文化如何促进或抑制创新?这项研究的结果表明,团队领导者主要将创新视为重新构想当前流程,工具和方法以提高护理标准的事物。另一方面,团队成员认为创新主要是由药物开发的管理方面(即管理和改善时间表,成本或质量)驱动的。尽管不认为是引入了全新产品的传统创新,但是这些类型的渐进式创新很重要,因为它们可以节省进入市场的时间,这可能意味着每天节省数百万美元。在宏观层面上,团队成员与领导者之间对创新的不同理解会在团队中造成压力,从而导致挫败感。此外,整个组织文化表明,整个团队的风险承受能力各不相同,各个团队的自主思考能力各不相同。这项研究增进了我们对生物制药行业创新和团队合作的理解,并为高级管理层,团队负责人和团队成员本着寻找下一个重大医学突破的精神努力调整工作实践的见解。

著录项

  • 作者

    Milheim, Shawn.;

  • 作者单位

    University of Pennsylvania.;

  • 授予单位 University of Pennsylvania.;
  • 学科 Management.;Business administration.;Organizational behavior.
  • 学位 Ed.D.
  • 年度 2014
  • 页码 195 p.
  • 总页数 195
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号